Nanobiotix S.A. (NBTX)
Develops nanoparticles injected into tumors to make radiation therapy more effective against cancer
$37.82-0.06%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+456.2%
The outlook
NBTX trades at $37.82 with strong analyst backing—the average target sits roughly 17% above the current price. The stock sits midway through its 52-week range and shows mixed momentum against its moving averages. Overall sentiment leans bullish based on available data.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 3 analysts
Price trendMixed vs its moving averages
52-week range62% of the way from its 52-week low to high
Price targetAvg target +17% vs current price
Analyst price target
~12-month · 3 analysts$44.41average target+17.4% vs now
Now $37.82
Low $29.13High $68.80
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.92B
52-wk high
$57.14
52-wk low
$6.09
50-day avg
$38.62
200-day avg
$29.63
Trailing P/E
—